PortfoliosLab logoPortfoliosLab logo
Envoy Medical Inc. (COCHW)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date
Apr 23, 2021

Highlights

Market Cap
$1.30M
Enterprise Value
-$1.34M
EPS (TTM)
-$1.21
Total Revenue (TTM)
$241.00K
Gross Profit (TTM)
-$497.00K
EBITDA (TTM)
-$15.36M
Year Range
$0.03 - $0.14
ROA (TTM)
-277.59%
ROE (TTM)
201.89%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Envoy Medical Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Envoy Medical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Envoy Medical Inc. (COCHW) has returned 70.69% so far this year and 101.21% over the past 12 months.


Envoy Medical Inc.

1D
2.15%
1M
27.69%
YTD
70.69%
6M
76.60%
1Y
101.21%
3Y*
20.87%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 23, 2021, COCHW's average daily return is +1.46%, while the average monthly return is +11.52%. At this rate, your investment would double in approximately 0.5 years.

Historically, 52% of months were positive and 48% were negative. The best month was Feb 2024 with a return of +605.9%, while the worst month was Oct 2023 at -81.9%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.

On a daily basis, COCHW closed higher 34% of trading days. The best single day was Feb 28, 2024 with a return of +508.9%, while the worst single day was Oct 3, 2023 at -55.3%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-0.00%33.68%27.69%70.69%
2025-14.35%6.25%-22.35%25.45%56.76%-45.61%43.06%-20.99%-5.76%7.98%24.63%-23.12%-16.70%
2024-15.00%605.88%-11.25%42.07%-67.15%0.60%0.20%49.70%6.67%-35.00%9.23%-17.78%133.50%
202312.87%98.18%-55.76%32.98%-0.40%0.20%-20.04%0.25%122.50%-81.91%84.47%-32.66%-47.37%
2022-39.11%-35.57%-19.36%4.04%-26.92%-34.47%-19.68%20.00%-44.25%-53.66%-32.26%80.95%-95.19%
202134.02%-7.48%54.84%-4.89%-31.00%1.59%3.13%6.05%12.86%57.98%

Benchmark Metrics

Envoy Medical Inc. has an annualized alpha of 3680.77%, beta of 0.30, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 26, 2021.

  • This stock participated in 131.49% of S&P 500 Index downside but only -42.14% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.30 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
3,680.77%
Beta
0.30
0.00
Upside Capture
-42.14%
Downside Capture
131.49%

Return for Risk

Risk / Return Rank

COCHW ranks 75 for risk / return — better than 75% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


COCHW Risk / Return Rank: 7575
Overall Rank
COCHW Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
COCHW Sortino Ratio Rank: 9090
Sortino Ratio Rank
COCHW Omega Ratio Rank: 8989
Omega Ratio Rank
COCHW Calmar Ratio Rank: 7575
Calmar Ratio Rank
COCHW Martin Ratio Rank: 6666
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Envoy Medical Inc. (COCHW) and compare them to a chosen benchmark (S&P 500 Index).


COCHWBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.36

0.90

-0.54

Sortino ratio

Return per unit of downside risk

2.84

1.39

+1.45

Omega ratio

Gain probability vs. loss probability

1.39

1.21

+0.18

Calmar ratio

Return relative to maximum drawdown

1.88

1.40

+0.48

Martin ratio

Return relative to average drawdown

2.83

6.61

-3.78

Explore COCHW risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Envoy Medical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Envoy Medical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Envoy Medical Inc. was 99.11%, occurring on Dec 15, 2023. The portfolio has not yet recovered.

The current Envoy Medical Inc. drawdown is 93.68%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.11%Jul 8, 2021616Dec 15, 2023
-29.41%Apr 30, 202117May 24, 202116Jun 16, 202133
-13.28%Jun 18, 20212Jun 21, 20216Jun 29, 20218

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Envoy Medical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Envoy Medical Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for COCHW relative to other companies in the Medical Devices industry. Currently, COCHW has a P/S ratio of 5.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items